Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Intern Med. 2000 Mar 7;132(5):369-72.

Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers.

Author information

  • 1Department of Internal Medicine, Ohio State University, Columbus 43210, USA.

Abstract

BACKGROUND:

Previous uncontrolled reports have suggested that HIV-seropositive persons develop an accelerated form of emphysema.

OBJECTIVE:

To characterize the risk for emphysema in a stable HIV-seropositive outpatient population.

DESIGN:

Controlled, cross-sectional analysis.

SETTING:

Midwestern urban community.

PARTICIPANTS:

HIV-seropositive persons (n = 114) without AIDS-related pulmonary complications and HIV-seronegative controls (n = 44), matched for age and smoking history.

MEASUREMENTS:

Measurement of pulmonary function, bronchoalveolar lavage, and high-resolution computed tomography of the chest.

RESULTS:

The incidence of emphysema was 15% (17 of 114) in the HIV-seropositive group compared with 2% (1 of 44) in the HIV-seronegative group (P = 0.025). The incidence of emphysema in participants with a smoking history of 12 pack-years or greater was 37% (14 of 38 persons) in the HIV-seropositive group compared with 0% (0 of 14 persons) in the HIV-seronegative group (P = 0.011). The percentage of cytotoxic lymphocytes in lavage fluid was much higher in HIV-seropositive smokers with emphysema.

CONCLUSIONS:

Infection with HIV accelerates the onset of smoking-induced emphysema. The results of this study support the emerging concept that cytotoxic lymphocytes may have an important role in emphysema pathogenesis.

PMID:
10691587
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk